AXIONProduct portfolio
One platform. Three markets.
A single core mechanism expressed across oncology, infection control and air treatment. Select a platform to see the detail and download the brochure.
Select a platform
Our products
Lead platform · Oncology
Extracorporeal ROS cancer therapy
Dialysis-like closed-loop therapy that activates focused Reactive Oxygen Species to neutralise circulating tumour cells and bloodborne pathogens — without systemic chemotherapy toxicity.
- NHS Phase I/II trial approved; sponsor and trial number assigned
- Pre-clinical programme successfully completed
- Targets the seed of metastasis, not just late-stage disease
- Outpatient procedure designed to complement standard of care
Advanced Air Treatment Units
Certified, NHS-tested and commercially supplied today into hospitals and surgical wards — the commercial engine that de-risks the clinical timeline.
- >99% pathogen destruction; 60–85% PM2.5 reduction
- CE, UKCA, UL and CARB certified for all major markets
- Active B2B commercial supply into NHS and industrial settings
- Recurring consumables and service model
Advanced Wound Dressings
Prototype complete with Smart Surface Technology — a long-lasting biostat coating giving 24-hour self-cleaning protection on a regulatory-light pathway.
- Supports cell regeneration, tissue repair and angiogenesis
- Barrier against hospital-acquired infections (HAI)
- CE submission Q3 Year 2, NHS pilot deployment planned
- Designed for high-volume hospital and chronic-wound use